Vascular Access Technologies, Inc

SAFECAD, The world's first patented retrograde Central Venous Access Device targets a $1.5 B Market, eliminates complications, saves lives, and reduces costs

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Norton, MA, US
  • Currency USD
  • Founded April 2009
  • Employees 3
  • Website vasctec.com

Company Summary

Vascular Access Technologies has developed SAFECVAD, the world's first patented retrograde central venous access catheter. Every year in the US, there are more than 150,000 severe complications and 11,000 people die to to complications associated with central venous access. The market size is $1.5B and the affordable care act specifically lists the complications that SAFECVAD solves.

Team

  • Jim Archetto
    CEO

    25+ years of successful medical device expertise and leadership, including 4 start-ups. The most successful, Radi Medical Systems wast acquired by St. Jude Medical for $250M

  • Lakshmikumar Pillai
    Founder, Vascular Access Technologies, Inc.

    Dr. Pillai is Chief of Vascular and Endovascular Surgery at West Virginia University founder of Vascular Access Technologies, Inc, and inventor of SAFECVAD.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free